Becton, Dickinson and Company Share Price Today: Live Updates & Key Insights

Becton, Dickinson and Company share price today is $154.13, up -1.53%. The stock opened at $156.46 against the previous close of $156.53, with an intraday high of $158.11 and low of $153.745.

Becton, Dickinson and Company Share Price Chart

Becton, Dickinson and Company

us-stock
To Invest in {{usstockname}}
us-stock

Becton, Dickinson and Company Share Price Performance

$154.13 -0.0153(-1.53%) BDX at 23 Mar 2026 12:11 PM Medical Instruments & Supplies
Lowest Today 153.745
Highest Today 158.11
Today’s Open 156.46
Prev. Close 156.53
52 Week High 186.16
52 Week Low 125.46
Day’s Range: Low 153.745 High 158.11
52-Week Range: Low 125.46 High 186.16
1 day return -
1 Week return -3.87
1 month return -16.36
3 month return -21.72
6 month return -17.42
1 year return -32.74
3 year return -35.57
5 year return -34.58
10 year return -

Becton, Dickinson and Company Institutional Holdings

Vanguard Group Inc 12.89

BlackRock Inc 9.76

T. Rowe Price Investment Management,Inc. 5.71

State Street Corp 4.88

Arnhold & S. Bleichroeder Advisers, LLC 4.09

JPMorgan Chase & Co 3.72

Massachusetts Financial Services Company 3.33

Vanguard Total Stock Mkt Idx Inv 3.16

T. Rowe Price Capital Appreciation 3.15

First Eagle Global A 2.83

Vanguard 500 Index Investor 2.57

Geode Capital Management, LLC 2.42

Franklin Resources Inc 2.37

Vanguard Mid Cap Index Institutional 2.17

Wellington Management Company LLP 1.86

T. Rowe Price Associates, Inc. 1.63

ClearBridge Advisors, LLC 1.55

NORGES BANK 1.33

iShares Core S&P 500 ETF 1.28

Fidelity 500 Index 1.28

Morgan Stanley - Brokerage Accounts 1.22

State Street® SPDR® S&P 500® ETF 1.19

Charles Schwab Investment Management Inc 1.12

American Century Companies Inc 1.10

Putnam Large Cap Value A 1.01

Putnam US Large Cap Value Equity 1.01

Veritas Asset Management LLP 1.01

Harris Associates L.P. 1.00

Nordea Investment Mgmt Bank Demark A/s 0.97

Bank of America Corp 0.95

Vanguard Value Index Inv 0.92

BlackRock Equity Dividend Instl 0.82

Vanguard Equity-Income Inv 0.77

State Street®HlthCrSelSectSPDR®ETF 0.75

JNL/T. Rowe Price Capital Appreciation A 0.69

Vanguard Mid-Cap Value ETF 0.62

Vanguard Institutional Index I 0.58

Vanguard Dividend Appreciation ETF 0.56

State St S&P 500® Indx SL Cl III 0.54

Vanguard Institutional 500 Index Trust 0.45

Becton, Dickinson and Company Market Status

Strong Buy: 4

Buy: 2

Hold: 11

Sell: 0

Strong Sell: 0

Becton, Dickinson and Company Fundamentals

Market Cap 55840.55 M

PB Ratio 1.7612

PE Ratio 25.5605

Enterprise Value 63315.56 M

Total Assets 55325.00 M

Volume 3723752

Becton, Dickinson and Company Company Financials

Annual Revenue FY25:21839000000 21839.0M, FY24:20178000000 20178.0M, FY23:19372000000 19372.0M, FY22:18870000000 18870.0M, FY21:20248000000 20248.0M

Annual Profit FY25:9924000000 9924.0M, FY24:9125000000 9125.0M, FY23:8170000000 8170.0M, FY22:8477000000 8477.0M, FY21:9427000000 9427.0M

Annual Net worth FY25:1678000000 1678.0M, FY24:1705000000 1705.0M, FY23:1484000000 1484.0M, FY22:1779000000 1779.0M, FY21:2092000000 2092.0M

Quarterly Revenue Q4/2025:5252000000 5252.0M, Q3/2025:5890000000 5890.0M, Q2/2025:5509000000 5509.0M, Q1/2025:5272000000 5272.0M, Q4/2024:5168000000 5168.0M

Quarterly Profit Q4/2025:2344000000 2344.0M, Q3/2025:2798000000 2798.0M, Q2/2025:2634000000 2634.0M, Q1/2025:2257000000 2257.0M, Q4/2024:2235000000 2235.0M

Quarterly Net worth Q4/2025:382000000 382.0M, Q3/2025:493000000 493.0M, Q2/2025:574000000 574.0M, Q1/2025:308000000 308.0M, Q4/2024:303000000 303.0M

About Becton, Dickinson and Company & investment objective

Company Information Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care

Organisation Medical Instruments & Supplies

Employees 70000

Industry Medical Instruments & Supplies

CEO Mr. Thomas E. Polen Jr.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Becton, Dickinson and Company FAQs

What is the share price of Becton, Dickinson and Company today?

The current share price of Becton, Dickinson and Company is $154.13.

Can I buy Becton, Dickinson and Company shares in India?

Yes, Indian investors can buy Becton, Dickinson and Company shares by opening an international trading and demat account with Motilal Oswal.

How to buy Becton, Dickinson and Company shares in India?

You can easily invest in Becton, Dickinson and Company shares from India by:

Can I buy fractional shares of Becton, Dickinson and Company?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Becton, Dickinson and Company?

Becton, Dickinson and Company has a market cap of $55840.55 M.

In which sector does Becton, Dickinson and Company belong?

Becton, Dickinson and Company operates in the Medical Instruments & Supplies sector.

What documents are required to invest in Becton, Dickinson and Company stocks?

To invest, you typically need:

What is the PE and PB ratio of Becton, Dickinson and Company?

The PE ratio of Becton, Dickinson and Company is 25.56 and the PB ratio is 1.76.